Pneumocystis pneumonitis in non-HIV-infected patients update

Pneumocystis Pneumonia: Third Edition, Revised and Expanded

Volumn , Issue , 2004, Pages 407-434

  Hughes, Walter T ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057279260     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (157)

1. Dworkin MS, Williamson J, Jones JL, Kaplan JE. Prophylaxis with trimethoprimsulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases. Clin Infect Dis 2001; 33:392-298.
2. Lamagni TL, Evans BG, Shigematsu M, Johnson EM. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001; 126:397-414.
3. Van Rood JJ, Oudshoorn M. The quest for a bone marrow donor—optimal or maximal HLA matching? N Engl J Med 1998; 339:1238-1239.
4. Nuesch R, Bellini C, Zimmerli W. Pneumocystis carinii pneumonia in human immunodeficiency virus (HlV)-positive and HIV-negative immunocompromised hosts. Clin Infect Dis 1999; 29:1519-1523.
5. Raychaudhuri SP, Hurley L, Siu S. Pneumocystis carinii pneumonia (PcP) in immunocompromised hosts: a comparative study among patients with and without AIDS (abstr TuB 2304). Int Conf AIDS 1996; 11(1):317.
6. Ewig S, Schafer H, Rockstroh JK, Luderitz B. Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae. Pneumologie 1996; 50:455-461.
7. Hughes WT, Price RA, Sisko F, Havron S, Kafatos AG, Schonland M, Smythe PM. Protein-calorie malnutrition: a host determinant for Pneumocystis carinii pneumonitis. Am J Dis Child 1974; 128:44-52.
8. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118: 704-711.
9. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane HC, Umacher C, Honig C, Longo DL. Pneumocystis carinii pneumonia: comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100:663-671.
10. Arend SM, Kroon FP, van’t Wout JW. Pneumocystis carinii pneuonia in patients without AIDS, 1980 through 1993. Arch Intern Med 1995; 155:2436-2441.
11. Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992; 267:832-837.
12. Varthalitis MD, Aoun M, Daneau D, Meunier F. Pneumocystis carinii pneumonia patients with cancer. Cancer 1993; 71:481-485.
13. Haron E, Bodey GP, Luna MA, Dekmezian R, Etling L. Has the incidence of Pneumocystis carini pneumonitis in cancer patients increased with the AIDS epidemic? Lancet 1988; 2:904-905.
14. Chave J-P, David S, Wauters J-P, van Melle G, Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of PcP in renal transplant recipients. AIDS 1991; 5:927-932.
15. Flament M, Couderc LJ, Aubert P, Epardeau B, Guedon J, Caubarrere I. Pneumocystose pulmonaire et transplantation renale: influence de l’epidemie de SIDA. Ann Med Interne (Paris) 1993; 144:61.
16. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996; 71:5-13.
17. th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, Sept 17-20: American Society of Microbiology, 1995.
18. Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME, Picardi M, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B, Cortelezzi A, Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschcini G, Cappucci MA, Russo D, Corvatta L, Martino P, Del Favero A. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA. Br J Haematol 2002; 117:379-386.
19. Byrd JC, Hargis JB, Kester KE, Hospenthal DR, Knutson SW, Diehl LF. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49:135-142.
20. Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AOS. Pneumocystis carinii in patients with primary brain tumors. Arch Neurol 1991; 48:406-409.
21. Slivka A, Wem U, Sjea WM, Loeffler JS. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 1993; 94:216-219.
22. Schiff D. Pneumocystis carinii pneumonia in brain tumor patients: risk factors and clinical features. J Neurooncol 1996; 27:235-240.
23. Kulke MH, Vance EA. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 1997; 25:215-218.
24. Siminski J, Kidd P, Phillips GD, Collins C, Ragu G. Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1991; 143:437-440.
25. Koibuchi Y, Iino Y, Yokoe T, Oyama T, Nakajima T, Morishita Y. Pneumocystis carinii pneumonia during treatment for recurrent breast cancer: a case report. Jpn J Clin Oncol 1995; 25:218-221.
26. Tattevin P, DiPalma M, Vittecog D. Pneumocystis carinii pneumonia in patients with breast cancer: are there contributing local factors? Clin Infect Dis 1998; 26: 1018.
27. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B Study 8811. Blood 1995; 85:2026-2037.
28. Lyytikainen O, Elonen E, Lautenschlager I, Jokipli A, Tittanen L, Ruutu P. Pneumocystis carinii pneumonia in adults with acute leukemia: is there a need for primary chemoprophylaxis? (letter) Eur J Haematol 1996; 56:188-189.
29. Bondo AY, White DA. Granulomatous Pneumocystis carinii pneumonitis in patients with malignancy. Thorax 2002; 57:435-437.
30. Wakefield AE, Miller RF, Guiver LA, Hopkin JM. Granulomatous Pneumocystis carinii pneumonia: DNA amplification studies on bronchoscopic alveolar lavage samples. J Clin Pathol 1994; 47:664-666.
31. Jojima H. Early diagnosis and treatment of pulmonary opportunistic infection by using polymerase chain reaction and beta-glucan in patients with hematological neoplasms. Kurme Med J 2002; 48:117-127.
32. Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB. Oral therapy for Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole vs trimetho-prim-dapsone. N Engl J Med 1990; 323:776-782.
33. Hughes WT, Leoung G, Kramer F, Bozzette S, Safrin S, Frame P, Clumeck N, Masur H, Lancaster D, Chan C, Lavelle J, Rosenstock J, Falloon J, Feinberg J, LaFon S, Rogers M, Sattler F. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993; 328:1521-1527.
34. Toma E, Thorne A, Singer J, Raboud J, Lemieux C, Trottier S, Bergeron MG, Tsoukas C, Falutz J, Lalonde R, Gaudreau C, Therrien R. Clindamycin with primaquine vs trimethoprim-sulfamethoxazole therapy for mild and moderate Pneumocystis carinii pneumonia in patients with AIDS. Clin Infect Dis 1998; 27:524-530.
35. Pareja JG, Garland R, Koziel H. Use of corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998; 113:1215-1224.
36. Declaux C, Zahar J-R, Amraoui G, Leleu G, Lebargy F, Brochard L, Schlemmer B, Brun-Buisson C. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clin Infect Dis 1999; 29:670-672.
37. Linden V, Karlen J, Olsson M, Palmer K, Ehren H, Henter JI, Kalin M. Successful extracorporeal membrane oxygenation in four children with malignant disease and severe Pneumocystis carinii pneumonia. Med Pediatr Oncol 1999; 32:25-31.
38. Hughes WT, Kuhn S, Chaudray S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297:1419-1426.
39. Poulsen A, Demeny AK, Bang PC, Nielsen G, Schmiegelow K. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 2001; 37:20-23.
40. Lemez P, Ryskova P, Votava V, Suchmova M, Jirasek A, Rubik I. Successful prevention of Pneumocystis carinii infection with 1,920 mg of trimethoprimsulfamethoxazole daily in patients with malignant hematopoietic diseases. Vnitr Lek 1995; 41:688-690.
41. Kritz A, Sepkowitz KA, Weiss M, Telford P, Sogoloff H, Kempin S, Armstrong D, Gee T. Pneumocystis carinii pneumonitis developing within one month of intensive chemotherapy for the treatment of acute lymphocytic leukemia. N Engl J Med 1991; 325:661-662.
42. Broyart A, Debard A, Rohrlich P, Rahimy C, Lkescoeur B, Vilmer E. When to initiate anti-Pneumocystis carinii prophylaxis in acute lymphoblastic leukemia treatment. Leukemia 1994; 8:216.
43. Wilbur RB, Feldman S, Malone WJ, Ryan M, Aur RJA, Hughes WT. Outcome of unstructured delivery of chemoprophylaxis for Pneumocystis carinii pneumonitis. Am J Dis Child 1980; 134:634-648.
44. Mustafa MM, Pappo A, Cash J, Winck NJ, Buchanan GR. Aerosolized pentamidine for the prevention of Pneumocystis carini pneumonia in children with cancer intolerant or allergic to trimethoprim-sulafmethoxazole. J Clin Oncol 1994; 12:258-261.
45. Weinthal J, Birones G, Gillan E, Hodder F, Cairo MS. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in pediatric leukemia patients undergoing immunosuppresive chemotherapy. Proc Annu Meet Am Soc Oncol 1993; 12:A1587.
46. O’Sullivan BP, Spaulding R. The use of aerosol pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia. Pediatr Pulmonol 1994; 18:228-231.
47. Brunvad MW, Collins C, Livingston RB, Raghu G. Pneumocystis carinii pneumonia associated with profound subset ratios during treatment for early-stage breast carcinoma. Cancer 1991; 67:2407-2409.
48. Fantin B, Joly V, Elbim C, Golmard J-L, Gougerot-Poocidalo M-A, Yeni P, Carbon C. Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms. Clin Infect Dis 1996; 22:1096-1098.
49. Nevez G, Guyot K, Totet A, Raccurt C, Dei-Cas E. Pulmonary colonization with Pneumocystis carinii in an immunosuppressed HIV-negative patient: detection and typing of the fungus by PCR. J Med Microbiol 2001; 50:198-200.
50. Gordon SM, LaRosa SP, Kalmadi S, Arrolliga AC, Avery RK, Truesdell-LaRosa L, Longworth DL. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28:240-246.
51. Hayes MJ, Torzillo PJ, Sheil AG, McCaughan GW. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant 1884; 8:499-503.
52. Colombo JL, Sammut PH, Langnas AN, Shaw BW. The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation 1992; 54: 621-624.
53. Torre-Cisneros J, De la Mata M, Pozo JC, Serrano P, Briceno J, Solorzano GM, Pera C, Sanchez-Guijo P. Randomized trial of weekly sulfadoxine/pyrimethamine vs daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pnemocystis carinii pneumonia after liver transplantation. Clin Infect Dis 1999; 29: 771-774.
54. Myers B, Borrego F, Papanicolaou G. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study. Liver Transplant 2001; 7:750-751.
55. Saukkonen K, Garland R, Koziel H. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Chest 1996; 109:1250-1255.
56. Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001; 33:1397-1405.
57. Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant 1995; 10:1194-1197.
58. Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation: impact of immuosup-pression. Transplantation 1996; 62:421-423.
59. Spieker C, Barenbrock M, Tepel M, Buchholz B, Rahn KH, Zidek W. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute therapy of acute renal allograft rejection with orthoclone (OKT3). Transplant Proc 1992; 24:2602-2603.
60. Reichenberger F, Dickenmann M, Binet I, Soler M, Bolliger C, Steiger J, Brunner F, Thiel G, Tamm M. Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transpl Infect Dis 2001; 3:2-7.
61. Oz HS, Hughes WT. Novel anti-Pneumocystis carinii effects of immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, siroli-mus and dexamethasone. J Infect Dis 1997; 175:901-904.
62. Sollinger HW, Belzer FO, Deierhof MH, Diethelm AG, Gonwa TA, Kauffman RS, Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT. RS-61443 (mycopheno-late mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg 1992; 216:513-519.
63. The Tricontinental Mycophenolate Mofetil Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal tansplantation. Transplantation 1996; 61:1029-1037.
64. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Mycopheno-late mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation 1996; 61:722-729.
65. Hennequin C, Page B, Roux P, Legendre C, Kreis H. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microb Infect Dis 1995; 14:122-126.
66. Uchida K, Nakayama H, Yoshida K, Hosaka K, Hasegawa A, Matsumoto T, Tateda K. Opportunistic pneumonia after kidney transplantation. Nihon Kokyuki Gakkai Zasshi 2001; 39:166-172.
67. Cisneros JM, Munoz P, Torre-Cisneros J, Gurgui M, Rodriguez-Hernandez MJ, Aguado JM, Echaniz A. and the Spanish Transplantation Infection Study Group. Pneumonia after heart transplantation: a multi-institutional study. Clin Infect Dis 1998; 27:324-324.
68. Cardenal R, Medrano FJ, Varela JM, Ordonez A, Regordan C, Rincon M, Martinez A, Calderon EJ. Pneumocystis carinii pneumonia in heart transplant recipients. Eur J Cardiothorac Surg 2001; 4:799-802.
69. Munoz P, Munoz RM, Palomo J, Rodriquez-Creixems M, Munoz R, Bouza E. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine 1997; 76:415-422.
70. Olsen SL, Renlund DG, O’Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole. Transplantation 1993; 56:359-362.
71. Janner D, Bork J, Baum M, Chinnock R. Pneumocystis carinii pneumonia in infants after heart transplantation. J Heart Lung Transplant 1996; 15:758-763.
72. Grossin P, Ippoliti GB, Coggi C, Cremashi P, Scaglia M, Minoli L. Pneumocystis carinii pneumonia in heart transplants. Infection 1993; 21:75-79.
73. Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart transplant recipients. Transplantation 1986; 41:725-729.
74. Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimethoprimsulfamethoxazole prophylaxis for Pneumocystis carinii infection in heart-lung and lung transplantation: how effective and for how long? Transplantation 1992; 53: 586-589.
75. Gryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, Hardesty RL, Trento A, Nalesnik MA, Dauber JH. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Am Rev Respir Dis 1988; 137(126):1268-1274.
76. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risks. Arch Intern Med 1995; 155:1125-1128.
77. Tuan IZ, Dennison D, Weisfdorf DJ. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992; 10:267-272.
78. Saito T, Seo S, Kanda Y, Shoji N, Ogasawara T, Murakami J, Tanosaki R, Taobinai K, Takaue Y, Mineishi S. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. Am J Hematol 2001; 67:206-209.
79. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87:237-246.
80. Meyers JD, Pifer LL, Sale GE, Thomas ED. The value of Pneumocystis carinii antibody and antigen detection for the diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 1979; 120:1283-1287.
81. Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis 1999; 29:1467-1471.
82. Mansharamani NG, Balachandran D, Vernovsk I, Garland R, Koziel H. Peripheral blood CD4 T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000; 118:712-720.
83. 4 lymphocyte count in a patient with P carinii pneumonia after autologous bone marrow transplantation. Bone Marrow Transplant 1995; 15: 977-978.
84. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Bone Marrow Transplant 1994; 14:247-252.
85. Feinstein MB, Mokhtari M, Ferreiro R, Stover DE, Jakubowski A. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance. Chest 2001; 120:1094-1100.
86. Vascocelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aerosolized pentamidine as Pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000; 6:35-43.
87. Maltezou HC, Petropoulos D, Choroszy M, Gardner M, Manzouranis EC, Rolston KV, Chan KW. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant 1997; 20:879-881.
88. Link H, Vohringer HF, Wingen F, Bragas B, Schwardt A, Ehninger G. Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT. Bone Marrow Transplant 1993; 11:403-406.
89. Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24:897-902.
90. McKay E, Richardson J. Pneumocystis carinii pneumonia associated with hypogammaglobulinemia. Lancet 1959; 2:713.
91. Burke BA, Good RA. Pneumocystis carinii infection. Medicine (Baltimore) 1973; 52:23-51.
92. Walzer PD, Schultz MG, Western KA, Robbins JB. Pneumocystis carinii pneumonia and primary immunodeficiency diseases. In Robbins JB, DeVita VT, Dutz W, Eds. Symposium on Pneumocystis carinii infection. Natl Cancer Inst Monogr 1976; 43:73-77.
93. Berrington JE, Flood TJ, Abinun M, Galloway A, Cant AJ. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Arch Dis Child 2000; 82:144-147.
94. Stephan JL, Viekova V, LeDeist F, Blanch S, Donadieu J, De Saint-Basile G, Durandy A, Griscelli C, Fischer A. Severe combined immunodeficiency; a retrospective single center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123:564-572.
95. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Planter D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrabamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of x-linked hyper-IgM syndrome. J Pediatr 1997; 131:47-54.
96. Heiming R, Beuschausen T, Liebner T, Seidenberg J, Roesler J. Life threatening Pneumocystis carinii pneumonia in a 4-month-old boy with hyper-IgM syndrome. Monatsscr Kinderheilkd 1993; 14:860-863.
97. Miller ML, Algayed IA, Yogev R, Chou PM, Scholl PR, Pachman LM. Atypical Pneumocystis carinii pneumonia in a child with hyper-IgM syndrome. Pediatr Pathol Lab Med 1998; 18:71-78.
98. Khawaja K, Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 2001; 84:508-511.
99. Oz HS, Hughes WT, Rehg JE, Thomas EK. Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model. Microb Pathogen 2000; 29:187-190.
100. Godeau B, Mainardi JL, Roudot-Thoraval F, Hachulla E, Guillevin L, Huong Du LT, Jarrousse B, Remy P, Schaeffer A, Piette JC. Factors associated with Pneumocystis carinii pneumonia in Wegener’s granulomatosis. Ann Rheum Dis 1995; 54: 991-994.
101. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 1999; 42:780-789.
102. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, Leavitt RY. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med 1995; 15:795-799.
103. Stegeman CA, Tervaert JWC, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Engl J Med 1996; 335:16-20.
104. Sy ML, Chin TW, Nussbaum E. Pneumocystis carinii pneumonia associated with inhaled corticosteroids in an immunocompetent child with asthma. J Pediatr 1995; 127:1000-1002.
105. Contini C, Villa MP, Romani R, Merolla R, Delia S, Ronchetti R. Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency. J Med Microbiol 1998; 47:329-333.
106. Abernathy-Carver KJ, Fan LL, Boguniewicz M, Larsen GL, Leung DY. Legionella and Pneumocystis pneumonias in asthmatic children on high doses of steroids. Pediatr Pulmonol 1994; 18:135-138.
107. Farr RW. Pneumocystis carinii pneumonia due to corticosteroids. South Med J 1992; 85:52-53.
108. Vallerand H, Cossart C, Milosevic D, Lavaud F, Leone J. Fatal Pneumocystis pneumonia in asthmatic patient treated with methotrexate. Lancet 1992; 339:1551.
109. Rothstein M, Minkowitz S, Rosenstreich DL. Pneumocystis carinii pneumonia presenting as asthma: increased bronchial hyperresponsiveness in Pneumocystis carinii pneumonia. Ann Allergy 1993; 70:141-146.
110. Kuitert LM, Harrison AC. Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma. Thorax 1991; 46:936-937.
111. Palange P, Serra P, Di Sabato F, Contini C, Giacocvazzo M. Pneumocystis carinii pneumonia in a patient with chronic obstructive pulmonary disease but no evident immunocompetence. Clin Infect Dis 1994; 19:543-544.
112. Royce FH, Blumberg DA. Pneumocystis carinii isolated from lung lavage fluid in an infant with cystic fibrosis. Pediatr Pulmonol 2000; 29:235-239.
113. Sing A, Geiger AM, Hogardt M, Heesemann J. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. J Clin Microbiol 2001; 39: 2717-1718.
114. Raychaudhuri SP, Siu S. Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases. Br J Dermatol 1999; 141: 528-530.
115. Kadoya A, Okada J, Iiluni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996; 23:1186-1188.
116. Duncan KO, Imaeda S, Milstone LM. Pneumocystis carinii pneumonia complicating methotrexate treatment of pityriasis rubra pilaris. J Am Acad Dermatol 1998; 39:276-278.
117. Rose C, Kern WV. Another case of Pneumocystis carinii pneumonia in a patient with dyskeratosis congenita (Zinsser-Cole-Engman syndrome). Clin Infect Dis 1992; 15:1056-1057.
118. Jacobs JL, Libby DM, Winters RA. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med 1991; 324:246-250.
119. Walzer PD. Pneumocystis carinii—new clinical spectrum? N Engl J Med 1991; 324:263-265.
120. Stiller RA, Paradis IL, Dauber JH. Subclinical pneumonitis due to Pneumocystis carinii in a young adult with elevated antibody titers to Epstein-Barr virus. J Infect Dis 1992; 166:926-930.
121. Tsai HC, Lee SS, Lin HH, Lu LY, Liu YC. Pneumocystis carinii pneumonia in systemic lupus erythematosus: a report of two cases. J Formos Med Assoc 2000; 100:699-702.
122. Galeazzi M, Sebastiani GD, Marroni P. Pneumocystis carinii pneumonia complicating selective CD4-T cell depletion induced by corticosteroid therapy in a patient with systemic lupus erythematosus (letter). Clin Exp Rheumatol 1993; 11:96-97.
123. Nguyen TB, Galezowski N, Taksin AL, Carlet J, Lavarde V. Pneumocystis carinii infection disclosing untreated systemic lupus erythematous. Rev Med Interne 1995; 16:146-149.
124. Wainstein E, Neira O, Guzman L. Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia. Rev Med Chil 1993; 121:1422-1425.
125. Foster HE, Malleson PN, Petty RE, Roberton DM, Cabral DA. Pneumocystis carinii pneumonia in childhood systemic lupus erythematosus. J Rheumatol 1996; 23: 753-756.
126. Podrebarac TA, Jovaisas A, Karsh J. Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus (letter). J Rheumatol 1996; 23:199-200.
127. Sharma CP, Chaudhary D, Behera D. Pneumocystis carinii pneumonia in a patient with active untreated systemic lupus erythematosus. Indian J Chest Dis Allied Sci 2001; 43:169-171.
128. Liam CK, Wang F. Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus. Lupus 1992; 1:379-385.
129. Lim KL, Powell RJ, Johnston ID. Pneumocystis carinii pneumonia following immunosuppressive therapy in systemic lupus erythematosus (letter; comment). Br J Rheumatol 1992; 31:643-644.
130. Matsuda T, Kimura A, Shiota T, Hashimoto S. A case of acute progressive pulmonary cystic disease associated with Pneumocystis carinii pneumonia in a non-HIV-infected patient. Nihon Kokyuki Gakkai Zasshi 2001; 39:508-513.
131. Rolland Y, Cantagrel A, Laroche M, Mazieres B. Pneumocystis carinii pneumopathy in rheumatoid polyarthritis treated by methotrexate in a patient with pulmonary asbestosis. Rev Med Interne 1998; 19:581-583.
132. Kitsuwa S, Matsunaga K, Kawai M, Tsuzi T, Kato K, Tani K, Okubo T. Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis—case report and review of literature. Ryu-machi 1996; 36:551-558.
133. Okuda Y, Oyama T, Oyama H, Miyamoto T, Takasugi K. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis. Ryumachi 1995; 35:699-704.
134. Oien KA, Black A, Hunter JA, Madhok R. Pneumocystis carinii pneumonia in a patient with rheumatoid arthritis, not on immunosuppressive therapy and in the absence of human immunodeficiency virus infection. Br J Rheumatol 1995; 34: 677-679.
135. Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 1997; 24:2299-2303.
136. Marshall D, Sturrock RD, Porter D, Capell HA. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis (letter). Thorax 1992; 47:67.
137. Wyss E, Kuhn M, Luzi HP, Reinhart WH. Fatal outcome of Pneumocystis carinii pneumonia under low-dose methotrexate and prednisone therapy for chronic rheumatoid arthritis. Case report and review of literature. Schweiz Rundsch Med Prax 1994; 83:449-452.
138. Stenger AA, Houtman PM, Bruyn GA, Eggink HF, Pasma HR. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand J Rheumatol 1994; 23:51-53.
139. Roux N, Flipo RM, Cortet B, Lafitte JJ, Tonnel AB, Duquesnoy B, Delcambre B. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rhum Engl Ed 1996; 63:453-456.
140. Vargas SL, Ponce CA, Hughes WT, Wakefield AE, Weitz JC, Donoso S, Uloa AV, Madrid P, Gould S, Latorre JJ, Avila R, Veneviste S, Gallo M, Belletti J, Lopez R. Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin Infect Dis 1999; 29:1489-1493.
141. Morgan DJ, Vargas SSL, Reyes-Mugica M, Walterspiel JN, Carver W, Gigliotti F. Identification of Pneumocystis carinii in the lungs of infants dying of sudden infant death syndrome. Pediatr Infect Dis J 2001; 20:306-309.
142. Sheldon WH. Subclinical Pneumocystis carinii pneumonitis. Am J Dis 1959; 97:267-274.
143. Guttler R, Singer PA, Axline SG, Greaves TS, McGill JJ. Pneumocystis carinii thyroiditis. Report of three cases and review of the literature. 1993; 153:1002.
144. Ragni M, Dekker A, DeRubertis FR, Watson CG, Skolnick ML, Goold SD, Finiki-otis MW, Doshi S, Meyers DJ. Pneumocystis carinii infection presenting as necrotizing thyroiditis and hypothyroidism. Am J Clin Pathol 1991; 95:489-493.
145. Smith MB, Hanauer SB. Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis (letter). N Engl J Med 1992; 327:497-498.
146. Quan VA, Saunders BP, Hicks BH, Sladen GE. Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia. BMJ 1997; 314: 363-364.
147. Khatchatourian M, Seaton TL. An unusual complication of immunosuppressive therapy in inflammatory bowel disease. Am J Gastroenterol 1997; 92:1558-1560.
148. Bernstein CN, Kolodny M, Block E, Shanahan F. Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. Am J Gastroenterol 1993; 88:574-577.
149. Scott AM, Myers GA, Harms BA. Pneumocystis carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: a role for perioperative prophylaxis in the cyclosporine era? Report of a case and review of the literature Dis Colon Rectum 1997; 40:973-976.
150. Varela JM, Fernandez-Alonso J, Wichmann I, Calderon EJ. Pneumocystis carinii investigation in patients with Wegener’s granulomatosis (letter). Br J Rheumatol 1998; 37:349-350.
151. Chung JB, Armstrong K, Schwartz JS, Albert D. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener’s granulomatosis undergoing immunosuppressive therapy. Arthritis Rheum 2000; 43:1841-1848.
152. Ulmer E, Mayr M, Binet I, Ebnother-Staub C, Dalquen P, Soler M, Tamm M. Granulomatous Pneumocystis carinii pneumonia in Wegener’s granulomatosis. Eur Respir J 2000; 15:213-216.
153. Yassine N, el Meziane A, Alaoi YA, Bartal M. Pneumocystis infection in a nonim-munocompromised patient. Rev Mal Respir 1996; 13:603-606.
154. Clinicopathological Conference. Pulmonary infiltrates in a 67-year old man. Am J Med 1991; 90:509-515.
155. Cano S, Capote F, Pereira A, Calderon E, Castillo J. Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest 1993; 104:376-381.
156. Ejzenberg B, Melles H, Melles C, Dias R, Baldacci ER, Okay Y. Aerobic bacteria, Chlamydia trachomatis, Pneumocystis carinii and cytomegalovirus as agents of severe pneumonia in small infants. Rep Inst Med Trop Sao Paulo 1996; 38:9-14.
157. Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, Cumsille F, Gigliotti F. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001; 32:855-861.